Biological markers: cognitive diseases and neurodegenerative changes in aging

Authors

  • Spencer Luiz Marques Payão Biólogo, Laboratório de Genética do Hemocentro, Faculdade de Medicina de Marília (Famema), Marília, SP, Brasil.

DOI:

https://doi.org/10.23925/2176-901X.2020v23i0p61-68

Keywords:

Aging, Biological Markers, Dementia, Alzheimer’s disease.

Abstract

Alzheimer's disease (AD) is the most common dementia; a condition that is neurodegenerative, progressive, insidious and has no cure. Considering the great impact of AD on the lives of the affected and their families; some tests with specificity between 80-95% indicate promising results of the total and phosphorylated liquor biomarkers and Aβ42 peptide for diagnosing AD. This approach may change in the future not only in terms of diagnosis, but also in therapy.

 

Author Biography

Spencer Luiz Marques Payão, Biólogo, Laboratório de Genética do Hemocentro, Faculdade de Medicina de Marília (Famema), Marília, SP, Brasil.

Biólogo, Laboratório de Genética do Hemocentro, Faculdade de Medicina de Marília (Famema), Marília, SP, Brasil.

 

Downloads

Published

2020-09-10

How to Cite

Payão, S. L. M. (2020). Biological markers: cognitive diseases and neurodegenerative changes in aging. Revista Kairós-Gerontologia, 23, 61–68. https://doi.org/10.23925/2176-901X.2020v23i0p61-68

Issue

Vol. 23 (2020): NÚMERO ESPECIAL 27 - REPRINTE 2019

Section

Papers

License

Kairós Gerontologia owns the copyright of all published material. The whole reproduction of the articles of this Journal in other publications or for any other purpose, by any means, requires a written permission of the editor of this journal. Partial reproductions of articles (abstracts, more than 500 words text, tables, figures and other illustrations) must have a permission written by the publisher and the authors.